InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of Oral IFB-088
For more informations, follow the link:
or visit InFlectis BioScience web site: http://www.inflectisbioscience.com/
Good news for CMT 1A and 1B
Published on January 7th, 2020
To read latest news
-
March 2nd, 2026From Antwerp to Action: Outcomes and Deliverables of the 2nd European CMT Specialists Conference
The Antwerp Milestone: A New Era for CMT Research -
February 3rd, 2026Clinical and Translational Advancements in CMT
A Comprehensive Analysis of the 2026 EURO-NMD Webinar Series on Charcot-Marie-Tooth Disease... -
January 23rd, 2026A Landmark 2026 Update: An important Review on Charcot-Marie-Tooth
The European CMT community welcomes a definitive new scientific review authored by... -
November 28th, 2025
Uniting Science & Community: the 2nd CMTSC
A Comprehensive Report from the 2nd European CMT Specialist Conference -
October 12th, 2025Nutrition and Charcot-Marie-Tooth
New Initiative Highlights the Critical Role of Nutrition for People with Charcot-Marie-Tooth... -
October 9th, 2025Patients as Partners: A Survey
A recent survey conducted by the European CMT Federation (ECMTF) and the... -
August 29th, 2025Highlights and Perspectives from the 2025 PNS annual meeting
The Peripheral Nerve Society (PNS) is the world’s leading scientific society... -
October 3rd, 2024Welcome ECRA!
-
April 24th, 2026Velkommen, Muskelsvindfonden!
The European CMT Federation (ECMTF) welcomes the addition of Muskelsvindfonden, the... -
February 12th, 2026Welcome, Qianlixing CMT Support Home!